Literature DB >> 23519814

Crystallization and preliminary X-ray crystallographic analysis of the human CKIP-1 pleckstrin homology domain.

Ping Li1, Yuli Xu, Xin Li, Mark Bartlam.   

Abstract

The casein kinase 2 interacting protein-1 (CKIP-1) is involved in many cellular functions, including apoptosis, signalling pathways, cell growth, cytoskeleton and bone formation. Its N-terminal pleckstrin homology (PH) domain is thought to play an important role in membrane localization and controls shuttling of CKIP-1 between the plasma membrane and nucleus. In this study, the human CKIP-1 PH domain was purified but problems were encountered with nucleic acid contamination. An S84D/S86D/S88D triple mutant designed to abolish nucleic acid binding was purified and successfully crystallized. Single crystals diffracted to 1.7 Å resolution and belonged to space group P4₃2₁2 with unit-cell parameters a=53.0, b=53.0, c=113.8 Å, α=β=γ=90.0°.

Entities:  

Keywords:  casein kinase 2 interacting protein-1; pleckstrin homology (PH) domain

Mesh:

Substances:

Year:  2013        PMID: 23519814      PMCID: PMC3606584          DOI: 10.1107/S1744309113003382

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  17 in total

1.  Role for the pleckstrin homology domain-containing protein CKIP-1 in phosphatidylinositol 3-kinase-regulated muscle differentiation.

Authors:  Alexias Safi; Marie Vandromme; Sabine Caussanel; Laure Valdacci; Dominique Baas; Marc Vidal; Gilbert Brun; Laurent Schaeffer; Evelyne Goillot
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

2.  Membrane trafficking: dual-key strategy.

Authors:  Toshiki Itoh; Pietro De Camilli
Journal:  Nature       Date:  2004-05-13       Impact factor: 49.962

3.  N-terminal PH domain and C-terminal auto-inhibitory region of CKIP-1 coordinate to determine its nucleus-plasma membrane shuttling.

Authors:  Shenli Xi; Yi Tie; Kefeng Lu; Minghua Zhang; Xiushan Yin; Jie Chen; Guichun Xing; Chunyan Tian; Xiaofei Zheng; Fuchu He; Lingqiang Zhang
Journal:  FEBS Lett       Date:  2010-02-18       Impact factor: 4.124

4.  The pleckstrin homology domain-containing protein CKIP-1 is involved in regulation of cell morphology and the actin cytoskeleton and interaction with actin capping protein.

Authors:  David A Canton; Mary Ellen K Olsten; Kyoungtae Kim; Amanda Doherty-Kirby; Gilles Lajoie; John A Cooper; David W Litchfield
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

5.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

6.  Pleckstrin domain homology.

Authors:  R J Haslam; H B Koide; B A Hemmings
Journal:  Nature       Date:  1993-05-27       Impact factor: 49.962

7.  Identification and characterization of CKIP-1, a novel pleckstrin homology domain-containing protein that interacts with protein kinase CK2.

Authors:  D G Bosc; K C Graham; R B Saulnier; C Zhang; D Prober; R D Gietz; D W Litchfield
Journal:  J Biol Chem       Date:  2000-05-12       Impact factor: 5.157

8.  Role for the pleckstrin homology domain-containing protein CKIP-1 in AP-1 regulation and apoptosis.

Authors:  Lingqiang Zhang; Guichun Xing; Yi Tie; Ying Tang; Chunyan Tian; Li Li; Libo Sun; Handong Wei; Yunping Zhu; Fuchu He
Journal:  EMBO J       Date:  2005-02-10       Impact factor: 11.598

9.  The Pleckstrin homology domain of CK2 interacting protein-1 is required for interactions and recruitment of protein kinase CK2 to the plasma membrane.

Authors:  Mary Ellen K Olsten; David A Canton; Cunjie Zhang; Paul A Walton; David W Litchfield
Journal:  J Biol Chem       Date:  2004-07-14       Impact factor: 5.157

10.  FAPPs control Golgi-to-cell-surface membrane traffic by binding to ARF and PtdIns(4)P.

Authors:  Anna Godi; Antonella Di Campli; Athanasios Konstantakopoulos; Giuseppe Di Tullio; Dario R Alessi; Gursant S Kular; Tiziana Daniele; Pierfrancesco Marra; John M Lucocq; M Antonietta De Matteis
Journal:  Nat Cell Biol       Date:  2004-04-25       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.